CyDex, University of Kansas deal

CyDex received exclusive, worldwide rights to the university's sulfoalkyl ether-alkyl ether cyclodextrin derivative for CyDex's Captisol sulfobutylether beta-cyclodextrin technology portfolio. The tec...